ABSTRACT. Efficacy and safety of intravenous and intramuscular vitamin K were compared prospectively in patients receiving total parenteral nutrition. Sixty patients randomly received either a 1-mg daily iv injection (iv group) or a 10-mg weekly injection group (im group). Efficacy was determined by the prolongation of twice-weekly prothrombin (PT) and activated partial thromboplastin (APTT) times. (1966)(1967)(1968)(1969)(1970)(1971)(1972)(1973)(1974)(1975) 
RESULTS
The safety of vitamin K administration was compared in the iv and im groups. Efficacy was also determined in the two groups using PT and APTT times. Efficacy data from the two groups in the present study was combined and compared to data from the 1981 study (no vitamin K).
Treatment Groups
Characteristics of the iv and im groups as well as similar data from the previous study are shown in Table   I . The iv and im groups were similar in age, sex, pretreat- To confirm that regular administration of vitamin K to patients on TPN was effective in maintaining normal PT times, the combined iv + im group was compared to the no-vitamin K group. The mean prolongation of the no-vitamin K group (3.7 sec) was significantly greater than that of the vitamin K group (1.9 sec) (p = 0.0004). Similarly, the no-vitamin K group had a higher percentage of PT times outside the normal range (p = 0.002). Because APTT times were not recorded in the previous study, comparison between patients in the vitamin K group and no-vitamin K group was not possible.
Adverse Reactions
The number of adverse reactions reported in the iv and im groups was similar (Table V) . Five 
